Stanford University
Showing 341-350 of 13,135 Results
-
Daniel Kwasi Amponsah
Affiliate, Department Funds
BioDr. Daniel Amponsah was born and raised in Loma Linda, California. He graduated with a BS in Biochemistry from Pacific Union College in Northern California and received his MD from Loma Linda University School of Medicine where he graduated AOA. He completed his internal medicine residency at Massachusetts General Hospital and was appointed the Simulation Chief his senior year. He is interested in pursuing an academic career in interventional cardiology with a focus on outcomes and health disparities. Prior research work has explored outcomes in ischemic time in patients with cardiogenic shock and STEMI with Dr. Anthony Hilliard, disparities in the management of aortic stenosis alongside Dr. Sammy Elmariah, defining type 2 MI using coronary CT with Dr. James Januzzi. He is presently engaged in assessing the potential applications of angiography-derived FFR and IMR across various coronary disease syndromes with Dr. Bill Fearon and investigating disparities in advanced structural interventions with Dr. Celina Yong.
-
Michael Amylon
Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsBone marrow transplantation (BMT) is a treatment modality which is being broadly applied to a growing number of disorders. Increasing success with BMT is offering improved survival to pediatric and adult patients with acute leukemia, chronic leukemia, lymphomas, and a variety of solid tumors as well as severe aplastic anemia.
-
Kanwaljeet S. Anand
Professor of Pediatrics (Pediatric Critical Care) and of Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsDr. Anand is a translational clinical researcher who pioneered research on the endocrine-metabolic stress responses of infants undergoing surgery and developed the first-ever scientific rationale for pain perception in early life. This provided a framework for newer methods of pain assessment, numerous clinical trials of analgesia/anesthesia in newborns, infants and older children. His research focus over the past 30+ years has contributed fundamental knowledge about pediatric pain/stress, long-term effects of pain in early life, management of pain, mechanisms for opioid tolerance and withdrawal. Current projects in his laboratory are focused on developing biomarkers for repetitive pain/stress in critically ill children and the mechanisms underlying sedative/anesthetic neurotoxicity in the immature brain. He designed and directed many randomized clinical trials (RCT), including the largest-ever pediatric analgesia trial studying morphine therapy in ventilated preterm neonates. He has extensive experience in clinical and translational research from participating in collaborative networks funded by NIMH, NINDS, or NICHD, a track-record of excellent collaboration across multiple disciplines, while achieving success with large research teams like the Collaborative Pediatric Critical Care Research Network (CPCCRN). He played a leadership roles in CANDLE (Condition Affecting Neuro-Development & Learning in Early infancy) and other activities of the Urban Child Institute and UT Neuroscience Institute. More recently, he led the NeoOpioid Consortium funded by the European Commission, which collected data from 243 NICUs in 18 European countries.
